Skip to main content
ConductScienceScienceDex

FY2023 NIH awards · Principal investigators

Pathology at University of Oklahoma Health Sciences Center

Oklahoma City, OK

Funding
$3.3M
$3,276,277
Awards
10
FY2023 NIH awards in Pathology
Principal investigators
6
6 lead a grant here, 0 co-investigators
Department rank
#54
of 91 · Ranking
  • NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
  • These are the awards in the Pathology row of the University of Oklahoma Health Sciences Center page.

Leads a grant in this department

6 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

  1. Ramesh, Rajagopal

    Leads 3 awards · $1,031,833

    • 1R01CA282735-01Department: NIH department code
      Engineered Nanoformulation for Immune-modulation in Cancer
      $543,107
      award amount
    • 5R01CA233201-05Department: NIH department code
      An improved IL-24 gene-based therapeutic for cancer
      $343,921
      award amount
    • 5R01CA254192-03Department: NIH department code
      Exosomes as carriers of cancer therapeutics
      $144,805
      award amount

  2. Bhattacharya, Resham

    Leads 2 awards · $756,100

    • 5R01CA260449-02Department: NIH department code
      Exploiting gold nanoparticle as a probe to identify therapeutic targets
      $379,984
      award amount
    • 5R01CA253391-03Department: NIH department code
      Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
      $376,116
      award amount

  3. Meric-Bernstam, Funda

    Leads 1 award · $567,912

    • 5R01CA273168-02Department: NIH department code
      Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
      $567,912
      award amount

  4. Ahnert, Jordi Rodon

    Leads 1 award · $382,199

    • 5R01CA242845-04Department: NIH department code
      Blocking tumor progression in therapy-responsive RET aberration-associated cancer
      $382,199
      award amount

  5. Ghosh, Asish Kumar

    Leads 2 awards · $368,764

    • 5R21CA274072-02Department: NIH department code
      Study Pro-Oncogenic Role of BCL6 in CLL Tumorigenesis
      $199,295
      award amount
    • 1R21CA280437-01Department: NIH department code
      Pro-Oncogenic Role of a Mitochondrial Lipid Kinase in CLL
      $169,469
      award amount

  6. Dwivedi, Shailendra Kumar Dhar

    Leads 1 award · $169,469

    • 1R21CA280507-01Department: NIH department code
      Role of miR-195 in Chemo-Resistant Ovarian Cancer
      $169,469
      award amount